depression from semaglutide Weight loss: Drugs like Ozempic may be linked to lower risk The risk of depression, anxiety,

Retatrutide is currently in Phase 3 clinical trials with Eli Lilly targeting FDA submission in 2026 and potential approval in 2027

Beyond-use date (BUD): Assigned to compounded medications by the pharmacist

How to stop diarrhea in infants and children Infants are especially susceptible to dehydration that can happen along with diarrhea

Lemas, PhD, assistant professor in the department of health outcomes and biomedical informatics, and faculty member at the Institute for Child Health Policy at University of Florida College of Medicine, said the FDA currently recommends that women stop using GLP-1s at least 2 months before conception due to fetal toxicity that was observed in some animal studies

Impacts (Effect Sizes): Recent Phase 2b (BELIEVE) and Pennington Biomedical data (March 2026) show that bimagrumab monotherapy produces ~10.8% total weight loss (exclusively fat mass) with a ~2.5% increase in lean mass

GLP-1 innovation in the future: Where the race is playing out The race to innovate is hardly over